1. Home
  2. GRFS vs BEPC Comparison

GRFS vs BEPC Comparison

Compare GRFS & BEPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GRFS
  • BEPC
  • Stock Information
  • Founded
  • GRFS 1940
  • BEPC 2019
  • Country
  • GRFS Spain
  • BEPC United States
  • Employees
  • GRFS N/A
  • BEPC N/A
  • Industry
  • GRFS Biotechnology: Pharmaceutical Preparations
  • BEPC Electric Utilities: Central
  • Sector
  • GRFS Health Care
  • BEPC Utilities
  • Exchange
  • GRFS Nasdaq
  • BEPC Nasdaq
  • Market Cap
  • GRFS 5.5B
  • BEPC 5.1B
  • IPO Year
  • GRFS 2006
  • BEPC N/A
  • Fundamental
  • Price
  • GRFS $7.27
  • BEPC $25.35
  • Analyst Decision
  • GRFS Strong Sell
  • BEPC Buy
  • Analyst Count
  • GRFS 1
  • BEPC 1
  • Target Price
  • GRFS N/A
  • BEPC $34.00
  • AVG Volume (30 Days)
  • GRFS 704.7K
  • BEPC 900.9K
  • Earning Date
  • GRFS 01-01-0001
  • BEPC 01-31-2025
  • Dividend Yield
  • GRFS N/A
  • BEPC 5.60%
  • EPS Growth
  • GRFS N/A
  • BEPC N/A
  • EPS
  • GRFS 0.27
  • BEPC N/A
  • Revenue
  • GRFS $7,814,096,584.00
  • BEPC $4,754,000,000.00
  • Revenue This Year
  • GRFS $9.31
  • BEPC $35.62
  • Revenue Next Year
  • GRFS $7.44
  • BEPC $6.12
  • P/E Ratio
  • GRFS $31.76
  • BEPC N/A
  • Revenue Growth
  • GRFS 7.21
  • BEPC 18.32
  • 52 Week Low
  • GRFS $5.30
  • BEPC $21.35
  • 52 Week High
  • GRFS $9.96
  • BEPC $35.14
  • Technical
  • Relative Strength Index (RSI)
  • GRFS 43.85
  • BEPC 30.38
  • Support Level
  • GRFS $7.00
  • BEPC $25.82
  • Resistance Level
  • GRFS $7.53
  • BEPC $26.81
  • Average True Range (ATR)
  • GRFS 0.24
  • BEPC 0.95
  • MACD
  • GRFS -0.01
  • BEPC -0.21
  • Stochastic Oscillator
  • GRFS 27.00
  • BEPC 5.74

About GRFS Grifols S.A.

As a vertically integrated plasma derivative producer, Spain-based Grifols collects plasma and then manufactures and sells plasma-derived products globally. By acquiring Talecris in 2011, Grifols dramatically expanded its plasma-derived product portfolio, and following the firm's Biotest acquisition in April 2022, the biopharma business contributed 84% of sales in 2023. Grifols also has smaller segments including diagnostics (10% of sales) and biosupplies.

About BEPC Brookfield Renewable Corporation

Brookfield Renewable is a globally diversified, multitechnology owner and operator of clean energy assets. The company's portfolio consists of hydroelectric, wind, solar, and storage facilities in North America, South America, Europe, and Asia, and totals over 20 gigawatts of installed capacity. Brookfield Renewable invests in assets directly, as well as with institutional partners, joint venture partners, and through other arrangements. The company offers two separate listings for investors: Brookfield Renewable Partners LP and Brookfield Renewable Corp.

Share on Social Networks: